Search Results

October 2022 "Understanding the activation of G protein-coupled receptors (GPCRs) is of paramount importance cardiovascular medicine due to the critical physiological roles of these receptors and their prominence as drug Although many cardiovascular GPCRs have been extensively studied as model receptors for decades, new As a result, there is an ongoing need to develop novel approaches to monitor and to modulate GPCR activation Read more at the source #DrGPCR #GPCR #IndustryNews

November 2022 "Adhesion G-protein-coupled receptors (aGPCRs) play key roles in a diversity of physiologies A hallmark of aGPCR activation is the removal of the inhibitory GAIN domain and the dipping of the cleaved The structures also reveal the uncharted structural information of GPCR/G12 coupling. A detailed analysis of the engagements allows us to design mutations that specifically enhance one pathway Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE

February 2022 Trevena Announces Submission of New Drug Application in China for OLINVYK® by its Partner announced that China’s National Medical Products Administration (NMPA) has accepted submission of a New Drug oliceridine) injection, a novel IV analgesic that has been approved in the United States by the Food and Drug Read more at the source #DrGPCR #GPCR #IndustryNews

Hello GPCR enthusiasts! We're here to share the latest GPCR news with you. Congratulations to Dr. GPCR Newsletter for updates! GPCR Binders, Drugs, and more Rational design of highly stabilized and selective adrenomedullin analogs Structure, Mechanism, and Drug Interactions of GPCRs, Ion Channels, and Transport Proteins (March 24 GPCR Ecosystem

Modulating GPCR and 14-3-3 protein interactions: prospects for CNS drug discovery. GPCR Binders, Drugs, and more Design of Drug Efficacy Guided by Free Energy Simulations of the β2 -Adrenoceptor Bioorthogonal Tethering Enhances Drug Fragment Affinity for G Protein-Coupled Receptors in Live Cells Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. FREE Symposium - IPI Surfacing (June 15, 2023) NEW GPCRs in drug discovery: challenges & solutions (June

co-internalization Kilian Roßmann , Ramona Birke , Joshua Levitz , Ben Jones , Johannes Broichhagen Design Multimodal Approaches to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28 Activation and Signaling Exploring Bias in GPCR Signaling and its Implication in Drug Development: A Binders, Drugs, and more G protein-coupled receptor (GPCR) pharmacogenomics Antibodies expand the scope extracellular loops on a soluble scaffold enabled the discovery of antibodies, which recognized native receptor Design

Binders, Drugs, and more Cloning and deorphanization of three inotocin (insect oxytocin/vasopressin-like Study of G protein-coupled receptors dimerization: From bivalent ligands to drug-like small molecules Respond to Drug-Like Molecules Accurately predicting GPCR P2Y1 membrane protein ligand binding with NEW Team Leader Antibody Discovery Staff Scientist (AC-TAP) in Database Development at Department of Drug Design and Pharmacology Faculty of Health and Medical Sciences Octant Apprentice Head of Human Resource

young adults with Down syndrome Novartis pays Schrödinger $150M, bets billions on the back end to form drug in Drug Discovery Orion Biotechnology has a new website GPCR Events, Meetings, and Webinars November Forum Conference November 26 - 28, 2024 | GPCRs-Targeted Drug Discovery Summit Europe December 10 - Multimodal Approaches to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28 Binders, Drugs, and more Kinetic Basis for the Design of Azobenzene-Based Photoswitchable A2a Adenosine

G protein-coupled receptors (GPCRs) are membrane-bound proteins that sense external stimuli and relay While GPCRs can exist as monomers, some types, like class C GPCRs, are obligate dimers, either as homodimers Class B1 GPCRs are an important subclass of GPCRs that include 15 receptors involved in regulating body for our understanding of GPCR function and signal transduction. Tate, New insights into GPCR coupling and dimerisation from cryo-EM structures.  

A bitter anti-inflammatory drug binds at two distinct sites of a human bitter taste GPCR Lior Peri ,   Innovation And 2025 Milestones Recursion and Exscientia have merged to enhance drug discovery GPCR Classes Multimodal Approaches to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28 drug binds at two distinct sites of a human bitter taste GPCR Photo-BQCA: Positive Allosteric Modulators drug repurposing to prevent and treat murine colitis and sepsis GPCRs in Oncology and Immunology Pancreatic

GPCR Symposium on Structural and Molecular Insights on GPCR Activation. GPCR Binders, Drugs, and more Molecular Characterization of Two Wamide Neuropeptide Signaling Systems Methods & Updates in GPCR Research A coiled-coil-based design strategy for the thermostabilization of Structure, Mechanism, and Drug Interactions of GPCRs, Ion Channels, and Transport Proteins (March 24 GPCR Ecosystem

We will be back next week with our regular weekly GPCR news digest. In the meantime, you can always check the  Classified GPCR News from the last weeks. GPCR Podcast. GPCR. Today is also the first session of our hands-on workshop with Dr. Sam Hoare. GPCR University content coming soon.

August 2022 "The cannabinoid CB1 receptor is the most abundant G protein coupled receptor (GPCR) in A variety of ligands for CB1 receptors have been developed as promising drug candidates for the treatment Guided Pharmacology of Membrane Proteins (BJP 75th Anniversary). " Read more at the source #DrGPCR #GPCR

Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Newsletter HERE

GPCR podcast with Dr. Nicole (Nicki) Perry-Hauser is now available What a fun chat! GPCR Ecosystem paid membership to enjoy everything Dr. GPCR has! ➡️https://bit.ly/3TCJVQQ #gpcr #drgpcr

Hi there GPCR enthusiasts! Join us this week for a deep dive into the world of GPCRs. GPCR Binders, Drugs, and more Adenosine A2A Receptor (A2AAR) Ligand Screening Using the 19F-NMR Probe GPCR Events, Meetings, and Webinars GPCRs in drug discovery: challenges & solutions (June 19 - 23, 2023 - 4, 2023) NEW Structure, Mechanism, and Drug Interactions of GPCRs, Ion Channels, and Transport Proteins GPCR Ecosystem

Kenakin’s Emerging Drug Hunter  lecture delivers exclusive, cutting-edge insights that help you move to decision faster, with fewer false starts   This isn’t textbook material—it’s real-world expertise designed The interpretation of high and low affinity binding sites  on GPCRs.   The analytical tools that shaped traditional affinity analysis were designed for simpler systems. Unlock “Rethinking Affinity” Now Only in Terry's Corner _____ #GPCR #BindingAffinity #Pharmacology

Greetings GPCR enthusiasts! Join us to explore the fascinating world of GPCRs. GPCR Symposium on Structural and Molecular Insights on GPCR Activation. , CTO of Exscientia discuss transforming drug discovery using their AI-driven platform Salipro Biotech - 4, 2023) Structure, Mechanism, and Drug Interactions of GPCRs, Ion Channels, and Transport Proteins GPCR Ecosystem

Human cells express over 800 G-protein-coupled receptors (GPCRs) to facilitate communication with the Capturing the dynamics of GPCR activation has always been a challenge because G protein activation in understanding of a key biological process but also provides a valuable map for pharmaceutical researchers to design With this high-resolution, dynamic view of GPCR activation, scientists can better tackle diseases by Time-resolved cryo-EM of G-protein activation by a GPCR. Nature (2024).

GPCR Binders, Drugs, and more In-depth molecular profiling of an intronic GNAO1 mutant as the basis for personalized high-throughput drug screening. The application of artificial intelligence to accelerate GPCR drug discovery. presented at the 23rd BioEquity Conference British Patient Capital Invests £10m in next-generation drug Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

Paper with his team: Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR China M Payne New ligands and new GPCR behaviors that produce unique drug profiles (i.e. intracellular ligands and November 14th : The Application of GPCR Ligand Kinetics to Candidate Design. November 21st : Unconventional GPCR Ligands as Drugs. 25 - 27, 2024 | 1st Virtual GPCR Forum Conference November 26 - 28, 2024 | GPCRs-Targeted Drug Discovery

that the affinity of Fzd for Dvl was not affected by Wnt ligands, in contrast to other members of the GPCR Read more at the source #DrGPCR #GPCR #IndustryNews

You can submit your logo design by November 1st, and registration is unnecessary to participate. GPCR Symposia? signaling mechanisms by NMR spectroscopy with stable-isotope labeled receptors GPCR Binders, Drugs, worth up to $674M 2023 Half-Year Financial Results and Exciting Developments at Aelis Farma Ion Channel Drug Chair of its Board of Directors Novo Nordisk and Evotec collaborate to launch LAB eN², a translational drug

targets and designing effective drug molecules. G protein-coupled receptors (GPCRs) are major drug targets, yet their complex and dynamic structures By using machine learning, AF2 can accurately predict the 3D structures of GPCRs with atomic-level accuracy The AlphaFold database encompasses over 200 million proteins, aiding structural biology, protein design Furthermore, AI's role in structural biology and drug design is set to spark innovation in automated

Our updated course schedule is designed to fit seamlessly into your routine, offering an enriched learning GPCR Event Spotlight Discovery on Target’s 19th Annual GPCR-Based Drug Discovery Targeting G Protein-Coupled drug design, including machine learning, new biophysical techniques, and medicinal chemistry. Register today for the GPCR Drug Discovery Conference and save $200 with discount code “ DRGPCR24 ”. Engaging multiple sclerosis by drugging a “simple” GPCR.

GPCR Symposium on GPCR Activation and Signaling on May 19th, 2023. GPCR Binders, Drugs, and more Discovery of SYD5115, a novel orally active small molecule TSH-R antagonist In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies Industry News A Current View of Allosteric GPCR Drug Discovery from the 2nd Annual GPCRs-Targeted Drug Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

GPCR Symposium on GPCR Activation and Signaling on May 19th, 2023. GPCR Binders, Drugs, and more Allosteric modulation of a human odorant receptor. Bioorthogonal Tethering Enhances Drug Fragment Affinity for G Protein-Coupled Receptors in Live Cells Reviews, GPCRs, and more G protein-coupled receptor-targeting antibody-drug conjugates: Current status Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.

GPCR Symposium on GPCR Activation and Signaling, May 19th, 2023. GPCR Binders, Drugs, and more Development of a 5-HT7 receptor antibody for the rat: the good, the bad Presented at AACR 2023 Highlights Exscientia’s Clinical and Preclinical Development The pathway of opioid drugs Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. GPCR Ecosystem

Structural and Molecular Insights into GPCR Function Structure-based design of novel melanin-concentrating design PhD student at the Department of Drug Design and Pharmacology Computational drug design postdoc at the Department of Drug Design and Pharmacology Software / database development PhD student at Department of Drug Design and Pharmacology Software / database development postdoc at the Department of Drug Design and Pharmacology Postdoc in Bioinformatics/Data Science at Department of Drug Design and Pharmacology

October 2022 "Pepducins are small-lipidated peptides designed from the intracellular loops of G protein-coupled receptors (GPCRs) that act in an allosteric manner to modulate the activity of GPCRs. To date, pepducins designed from numerous GPCRs have been studied for their impact on pathologic conditions This review will focus in particular on pepducins designed from protease-activated receptors, C-X-C motif Read more at the source #DrGPCR #GPCR #IndustryNews